Cardinal Health, Inc. is featured as one of the top 10 investments during a recession. Citi upgraded CAH from Neutral to Buy, with a price target raise from $190 to $244, citing confidence in the growth of specialist assets and strong performance in pharmaceutical distribution.

Citi emphasizes Cardinal Health’s expansion in specialist business, particularly new MSO assets like Solaris Health, expected to increase efficiency and revenue. The company remains cautious on Global Medical Products and Distribution but sees potential upside compared to consensus forecasts.

Cardinal Health, Inc. is a major U.S. healthcare services and products company based in Dublin, Ohio. It distributes pharmaceuticals and medical supplies globally and manufactures medical products, with two main segments: Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution.

Investors looking for AI stocks with high upside potential and lower risk may find better options than CAH. For those interested in an undervalued AI stock with potential benefits from tariffs and onshoring trends, a free report on the best short-term AI stock is available.

No disclosures were made in the article.

Read more at Yahoo Finance: Cardinal Health, Inc. (CAH) Shares Gain Favor as Citi Turns Bullish on Specialist Assets